NSE › Healthcare

Aurobindo Pharma Limited (AUROPHARMA)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,554.70-1.61%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹8,853 cr

Revenue YoY

+5.6%

Net profit

₹921 cr

Profit YoY

+2.0%

EPS

₹15.86

EPS estimate

₹16.31

Net margin

10.4%

EPS came in at 15.86 against a street estimate of 16.31 — a miss of 2.8%.

Key statistics

Market cap

₹90,910 cr

P/E

26.2

Forward P/E

8.2

P/B

2.40

Book value

₹652.31

EPS (TTM)

₹60.36

52-week high

₹1,636.80

52-week low

₹1,016.10

50-day MA

₹1,512.52

200-day MA

₹1,318.95

Beta

0.02

Analyst view

with an average price target of ₹1,570.83.

Shareholding

Promoters

54.83%

Institutions

29.20%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aurobindo Pharma Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.